Australasian Journal of Dermatology · 2005 · 13 citations · 14 references
MedicineDermatologyPharmacologyDermatopathologyDrug-induced Skin ReactionsInflammatory DermatosesInflammatory Skin DiseasesInterferon-based TherapyMultiple SclerosisMultiple Sclerosis PharmacotherapyCutaneous Drug EruptionsDrug-induced Skin EruptionsInterferon-mediated PathologyMultiple Sclerosis PathologyMultiple Sclerosis Therapy
A 32-year-old woman with multiple sclerosis who developed non-injection-site-related fixed drug eruption with interferon-beta-1b. Erythematous plaques started appearing 1 month after the drug was introduced, and increased in number following each administration. The histopathology of a skin biopsy was consistent with fixed drug eruption. The drug was subsequently ceased, with resolution of the rash 6 weeks later.
14
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
Neurology · 1993 · 2.1K citations
Pharmacy, Neurology, Pharmacotherapy +14
Wiwat Korkij · Archives of Dermatology · 1984 · 130 citations
Topical provocation of fixed drug eruption
Kristiina Alanko, S Stubb, Sakari Reitamo · British Journal of Dermatology · 1987 · 126 citations
Medicine, Dermatology, Pharmacology +10